Back to home

Product info

October 2020/RESP-764

Product info
Frequently asked Questions about Easyhaler®

Frequently asked Questions about Easyhaler®

Product info
Easyhaler & Asthma Guidelines

Easyhaler & Asthma Guidelines

Product info
Easyhaler Budesonide (budesonide)

Easyhaler Budesonide (budesonide)

Healthcare professionals
What is wehale.life

What is wehale.life

Product info
Easyhaler Product Family

Easyhaler Product Family

Product info
Fobumix Easyhaler (budesonide / formoterol fumarate dihydrate)

Fobumix Easyhaler (budesonide / formoterol fumarate dihydrate)

Product info
Fusacomb Easyhaler (salmeterol xinafoate / fluticasone propionate)

Fusacomb Easyhaler (salmeterol xinafoate / fluticasone propionate)

Product info
Orion Pharma – DPI expert

Orion Pharma – DPI expert

Product info
What is MART?

What is MART?

(Maintenance and Reliever Therapy)?


Read more





ORIONPHARMA.CO.UK

 

Full prescribing information available here

 

MAY 2021 / RESP-330b(3)

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.

Orion Pharma (UK) Ltd, Abbey Gardens, 4 Abbey Street, Reading, RG1 3BA, UK | Tel: +44 1635 520 300 | February 2021 / RESP-330(1)
Policies Contact us Orion Corporation 2021